Clin Chem Lab Med. 2008;46(12):1664-86.

Cystatin C: current position and future prospects.

Séronie-Vivien S, Delanaye P, Piéroni L, Mariat C, Froissart M, Cristol JP; SFBC "Biology of renal function and renal failure" working group.

Source

Département de Biologie Clinique, Institut Claudius Regaud, Université Paul Sabatier, Toulouse, France. seronie-vivien.sophie@claudiusregaud.fr

Abstract

Cystatin C is a low-molecular-weight protein which has been proposed as a marker of renal function that could replace creatinine. Indeed, the concentration of cystatin C is mainly determined by glomerular filtration and is particularly of interest in clinical settings where the relationship between creatinine production and muscle mass impairs the clinical performance of creatinine. Since the last decade, numerous studies have evaluated its potential use in measuring renal function in various populations. More recently, other potential developments for its clinical use have emerged. This review summarises current knowledge about the physiology of cystatin C and about its use as a renal marker, either alone or in equations developed to estimate the glomerular filtration rate. This paper also reviews recent data about the other applications of cystatin C, particularly in cardiology, oncology and clinical pharmacology.

PMID:: 18973461; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Save items

Related citations in PubMed

Review [Cystatin C: current step and future prospects]. [Ann Biol Clin (Paris). 2008]
Review [Cystatin C: current step and future prospects].
Séronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP, Groupe de travail "Biologie des fonctions rénales et de l'insuffisance rénale" de la SFBC. Ann Biol Clin (Paris). 2008 May-Jun; 66(3):301-23.
Review Serum cystatin C as a marker of glomerular filtration rate. [Curr Opin Nephrol Hypertens. 2...]
Review Serum cystatin C as a marker of glomerular filtration rate.
Madero M, Sarnak MJ, Stevens LA. Curr Opin Nephrol Hypertens. 2006 Nov; 15(6):610-6.
Cystatin C a marker for renal function after exercise. [Int J Sports Med. 2009]
Cystatin C a marker for renal function after exercise.
Mingels A, Jacobs L, Kleijnen V, Wodzig W, Dieijen-Visser M. Int J Sports Med. 2009 Sep; 30(9):668-71. Epub 2009 Jun 18.
Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C. [Clin Chem Lab Med. 2009]
Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C.
Conti M, Moutereau S, Esmilaire L, Desbene C, Lallali K, Devanlay M, Durrbach A, Manivet P, Eschwège P, Loric S. Clin Chem Lab Med. 2009; 47(12):1553-6.
Creatinine and cystatin C: what are the values? [Kidney Int. 2009]
Creatinine and cystatin C: what are the values?
Fried LF. Kidney Int. 2009 Mar; 75(6):578-80.

See reviews... See all...

Cited by 3 PubMed Central articles

Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. [PLoS One. 2010]
Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis.
Wilson ME, Boumaza I, Lacomis D, Bowser R. PLoS One. 2010 Dec 9; 5(12):e15133. Epub 2010 Dec 9.
Cystatin C as a marker of acute kidney injury in the emergency department. [Clin J Am Soc Nephrol. 2010]
Cystatin C as a marker of acute kidney injury in the emergency department.
Soto K, Coelho S, Rodrigues B, Martins H, Frade F, Lopes S, Cunha L, Papoila AL, Devarajan P. Clin J Am Soc Nephrol. 2010 Oct; 5(10):1745-54. Epub 2010 Jun 24.
Physical activity and rapid decline in kidney function among older adults. [Arch Intern Med. 2009]
Physical activity and rapid decline in kidney function among older adults.
Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple LS, de Boer I, Sarnak M, Shlipak M, Siscovick D, Kestenbaum B. Arch Intern Med. 2009 Dec 14; 169(22):2116-23.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cystatin C: current position and future prospects.
Cystatin C: current position and future prospects.
Clin Chem Lab Med. 2008 ;46(12):1664-86.

PubMed
Variceal bleeding : pharmacological treatment and prophylactic strategies.
Variceal bleeding : pharmacological treatment and prophylactic strategies.
Drugs. 2008 ;68(16):2303-24. doi: 10.2165/0003495-200868160-00004.

PubMed
Membrane-induced folding of the cAMP-regulated phosphoprotein endosulfine-alpha.
Membrane-induced folding of the cAMP-regulated phosphoprotein endosulfine-alpha.
Biochemistry. 2008 Nov 25 ;47(47):12357-64.

PubMed
Motor threshold in transcranial magnetic stimulation: the impact of white matter...
Motor threshold in transcranial magnetic stimulation: the impact of white matter fiber orientation and skull-to-cortex distance.
Hum Brain Mapp. 2009 Jul ;30(7):2044-55.

PubMed
Effects of hypoxia on glucose transport in primary equine chondrocytes in vitro ...
Effects of hypoxia on glucose transport in primary equine chondrocytes in vitro and evidence of reduced GLUT1 gene expression in pathologic cartilage in vivo.
J Orthop Res. 2009 Apr ;27(4):529-35.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Cystatin C: current position and future prospects.

Collaborators (26)